Courts Rule that Prempro Causes Cancer, but FDA Still Promotes It

Courts Rule that Prempro Causes Cancer, but FDA Still Promotes It

December 13, 2011

Print This Post

Despite large pay outs to victims, Pfizer keeps selling the hormone replacement drug and the government keeps trying to make sure there’s no competition from the natural alternative!
This past week, a court told Pfizer Inc., the multinational pharmaceutical company, to pay $72.6 million in damages to three women. Each had developed breast cancer after taking the company’s hormone replacement drug, Prempro (made from pregnant mares’ urine), for treatment of their menopause symptoms. So why is this drug still being sold?
In 2002, the National Institutes of Health sponsored a Women’s Health Initiative study that showed Prempro is linked to cancer. The research demonstrated that Prempro, which is already known to increase the risk of breast cancer, also makes it more likely that the cancer will advance quickly and prove fatal.
Read the full story